MSB 3.21% $1.13 mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-59

  1. 7,150 Posts.
    lightbulb Created with Sketch. 1832
    Congrats to all SH. I am not in but appreciate today’s news in increasing recovery and reducing death rates. Will become a SH soon.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.